Publication | Closed Access

In situ engineering of mRNA-CAR T cells using spleen-targeted ionizable lipid nanoparticles to eliminate cancer cells

NanomedicineEngineeringMedicineNano-drug DeliveryCancer VaccinesTumor TargetingBiomedical EngineeringCancer CellsMrna-car T CellsImmunotherapyCell EngineeringSitu EngineeringBiomolecular Engineering